🇺🇸 FDA
Pipeline program

gemcitabine

HKURO202401

Phase 2 small_molecule active

Quick answer

gemcitabine for Muscle Invasive Bladder Urothelial Carcinoma is a Phase 2 program (small_molecule) at Yung NA with 1 ClinicalTrials.gov record(s).

Program details

Company
Yung NA
Indication
Muscle Invasive Bladder Urothelial Carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials